Search

Your search keyword '"Dellapiana, Gabriela"' showing total 27 results
Start Over Author "Dellapiana, Gabriela"
27 results on '"Dellapiana, Gabriela"'

2. Sweating it out Exercise in pregnancy: Explore the detriments of activity restriction, ACOG recommendations, and the benefits and safety precautions for exercising during pregnancy

Author

Dellapiana, Gabriela

Subjects
Pregnancy, Music industry, Pregnant women, Type 2 diabetes, Health, American College of Obstetricians and Gynecologists
Abstract

'Is it OK for me to work up a sweat during pregnancy?' The answer is a resounding yes! Exercise during pregnancy is safe and recommended for most patients, as it [...]

Published
2024

8. Complement blockade with eculizumab for treatment of severe Coronavirus Disease 2019 in pregnancy: A case series

Author

Burwick, Richard M., primary, Dellapiana, Gabriela, additional, Newman, Rachel A., additional, Smithson, Sarah D., additional, Naqvi, Mariam, additional, Williams, John, additional, Wong, Melissa S., additional, Bautista, Martha, additional, Gaden, Anna, additional, Kazani, Shamsah D., additional, Dunn, Derek A., additional, Ma, Mark H., additional, Mitter, Sanjay, additional, Monteleone, Jonathan P. R., additional, Ortiz, Stephan R., additional, Ghandehari, Sara, additional, Merin, Noah, additional, Zakowski, Mark I., additional, and Karumanchi, S. Ananth, additional

Published
2022
Full Text
View/download PDF

16. Prophylactic postoperative antibiotics after emergent cesarean delivery and risk of postpartum infection or wound complication.

Author

Dellapiana, Gabriela, Levian, Candace, Gubernick, Lindsay, and Burwick, Richard M.

Subjects
*CESAREAN section, *KEYWORD searching, *ASEPSIS & antisepsis, *PUERPERIUM, *SKIN care products, *ANTIBIOTICS, *ANTIBIOTIC prophylaxis
Abstract

Background Emergent cesarean delivery (CD) carries a high risk for postpartum infection. In cases with a “splash” povidone-iodine (PI) skin preparation, prophylactic postoperative antibiotics (PP-Abx) are sometimes utilized, but the benefit is unclear. Objective To evaluate if the use of PP-Abx decreases postpartum infection after emergent CD with “splash” PI skin preparation. Study design Cohort study of patients undergoing emergent CD with PI skin preparation from July 2012 to April 2020 at a single institution. Cases were identified using a natural language search engine, DEEP-6, with key terms “emergent” and “cesarean delivery.” Patients with chorioamnionitis or non-PI skin preparation (e.g. chlorhexidine) were excluded. The primary exposure was use of PP-Abx. The primary outcome was postpartum infection or wound complication, defined as a composite: endometritis, wound infection, cellulitis, seroma, hematoma, or intra-abdominal abscess. Rates of postpartum infection or wound complication were stratified by use of PP-Abx. Demographic and labor characteristics were evaluated as confounders. Statistics by χ2, t-test, and logistic regression (α = 0.05). Results In total, 481 patients underwent emergent CD; of those, 370 had PI skin preparation and were included. PP-Abx were given in 43% (160/370) of cases, including: cefazolin (n = 137), gentamicin/clindamycin (n = 18), azithromycin (n = 3), and vancomycin (n = 2). Those receiving PP-Abx were similar to those who did not, except the PP-Abx group was younger with longer CD duration. The rate of postpartum infection or wound complication was no different in patients who received PP-Abx compared to those who did not (12.6% vs. 9.5%, p = .34). This finding remained unchanged after multivariable adjustment (aOR 1.2, CI 0.61–2.4, p = .60). Moreover, the rate of postpartum infection or wound complication did not vary by antibiotic choice. Conclusions After emergent CD with PI skin preparation, routine use of prophylactic postoperative antibiotics does not appear to reduce the rate of postpartum infection or wound complication, which is important as we consider antibiotic stewardship. More studies are needed to identify treatments that decrease infectious morbidity with emergent CD. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

24. Preferential use of dexamethasone for fetal lung maturation in severe COVID-19

Author

DELLAPIANA, Gabriela, NAQVI, Mariam, LEGGETT, Cecilia, THOLEMEIER, Lauren, and BURWICK, Richard M.

Subjects
Adult, Compassionate Use Trials, Alanine, SARS-CoV-2, Oxygen Inhalation Therapy, COVID-19, Antiviral Agents, Severity of Illness Index, Article, Adenosine Monophosphate, Dexamethasone, Treatment Outcome, Fetal Organ Maturity, Pregnancy, Humans, Female, Obesity, Respiratory Insufficiency, Glucocorticoids
Published
2020

Catalog

Books, media, physical & digital resources
See catalog results